<p><strong>Ovarian Cancer</strong>: Topotecan for injection, as a single agent, is indicated for the treatment of patients with metastatic&nbsp;carcinoma&nbsp;of the ovary after disease progression on or after initial or subsequent&nbsp;chemotherapy.<br />
<br />
<strong>Small Cell Lung Cancer</strong>: Topotecan for injection, as a single agent, is indicated for the treatment of patients with small cell&nbsp;lung cancer&nbsp;with platinum-sensitive disease who progressed at least 60 days after initiation of first-line chemotherapy.<br />
<br />
<strong>Cervical Cancer</strong>: Topotecan for injection in combination with&nbsp;cisplatin&nbsp;is indicated for the treatment of patients with Stage IV-B,&nbsp;recurrent, or persistent carcinoma of the&nbsp;cervix&nbsp;not amenable to curative treatment.</p>